UNICREDIT BANK/CALL/ABBVIE/220/0.1/18.12.24 Share Price

Warrant

DE000HC3LFT8

Real-time BOERSE MUENCHEN 11:11:58 28/05/2024 pm IST
0.02 EUR +1,900.00% Intraday chart for UNICREDIT BANK/CALL/ABBVIE/220/0.1/18.12.24
Current month-97.96%
1 month-97.30%
Date Price Change
28/24/28 0.02 +1,900.00%
27/24/27 0.001 -96.77%
24/24/24 0.031 +14.81%
23/24/23 0.027 -3.57%
22/24/22 0.028 -24.32%

Real-time BOERSE MUENCHEN

Last update May 28, 2024 at 11:11 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC3LFT
ISINDE000HC3LFT8
Date issued 27/01/2023
Strike 220 $
Maturity 18/12/2024 (204 Days)
Parity 10 : 1
Emission price 0.43
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 0.48
Lowest since issue 0.001

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
157.1 USD
Average target price
182.3 USD
Spread / Average Target
+16.05%
Consensus